Combining the farnesyltransferase inhibitor lonafarnib with paclitaxel results in enhanced growth inhibitory effects on human ovarian cancer models in vitro and in vivo-Reference-Cited by-同舟云学术

Combining the farnesyltransferase inhibitor lonafarnib with paclitaxel results in enhanced growth inhibitory effects on human ovarian cancer models in vitro and in vivo

Published:2008-04 Issue:1 Volume:109 Page:97-106
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Taylor Stacey A.,Marrinan Cindy H.,Liu Gongjie,Nale Lissette,Bishop W. Robert,Kirschmeier Paul,Liu Ming,Long Brian J.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference29 articles.

1. Ovarian cancer: epidemiology, biology, and prognostic factors;Holschneider;Semin Surg Oncol,2000

2. Randomized intergroup trial of cisplatin–paclitaxel versus cisplatin–cyclophosphamide in women with advanced epithelial ovarian cancer; three year results;Piccart;J Natl Cancer Inst,2000

3. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group Study;Ozols;J Clin Oncol,2003

4. Cancer statistics, 2006;Jemel;CA Cancer J Clin,2006

5. Thematic review series: lipid posttranslational modifications: farnesyl transferase inhibitors;Basso;J Lipid Res,2006

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies;Medicinal Research Reviews;2024-03-26

2. Phenothiazine- and Carbazole-Cyanochalcones as Dual Inhibitors of Tubulin Polymerization and Human Farnesyltransferase;Pharmaceuticals;2023-06-16

3. Targeted therapy for mucinous ovarian carcinoma: evidence from clinical trials;International Journal of Gynecologic Cancer;2022-09-06

4. Paclitaxel and cancer treatment: Non-mitotic mechanisms of paclitaxel action in cancer therapy;Paclitaxel;2022

5. Triggered release of paclitaxel from magnetic solid lipid nanoparticles by magnetic hyperthermia;Materials Science and Engineering: C;2018-11